VassiliosA.DimitropoulosMD
Dermatology • Darien, ILDermatologic Surgery
Assistant Professor and Director of Mohs and Dermatological Surgery University of Illinois Chicago
Dr. Dimitropoulos is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
8110 S. Cass Ave.
Darien, IL 60561Phone+1 630-920-1900Fax+1 630-920-1901- Is this information wrong?
Summary
- Dr. Vassilios Dimitropoulos is a dermatologist in Saint Joseph, MI and is affiliated with multiple hospitals in the area, including Lakeland Medical Center, St. Joseph, AMITA Health Adventist Medical Center Bolingbrook, Evanston Hospital, AMITA Health Resurrection Medical Center - Chicago, NorthShore Skokie Hospital, Highland Park Hospital, Glenbrook Hospital, and Battle Creek Veterans Affairs Medical Center. He received his medical degree from Rush Medical College and has been in practice 16 years. He specializes in dermatologic surgery and is experienced in sclerotherapy, general dermatology, dermatologic surgery, cosmetic dermatology, and cryosurgery.
Education & Training
University of Michigan Health SystemResidency, Dermatology, 2002 - 2005
Rush University Medical CenterInternship, Internal Medicine, 2001 - 2002
Rush Medical College of Rush University Medical CenterClass of 2001
Certifications & Licensure
MI State Medical License 2004 - 2026
IL State Medical License 2001 - 2026
IN State Medical License 2020 - 2025- American Board of Dermatology Dermatology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
- Fellow (FAAD) American Academy of Dermatology
Clinical Trials
- A Study Comparing Different Dosing Regimens of Ixekizumab (LY2439821) in Participants With Moderate to Severe Plaque Psoriasis Start of enrollment: 2015 Aug 01
- Evaluation of the Efficacy and Safety of Lebrikizumab (LY3650150) in Moderate to Severe Atopic Dermatitis (ADvocate1) Start of enrollment: 2019 Sep 24
- Study to Assess the Safety and Efficacy of Lebrikizumab (LY3650150) in Adolescent Participants With Moderate-to-Severe Atopic Dermatitis Start of enrollment: 2020 Feb 11
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsReasons behind the ink.Dimitropoulos, Brown Cw, Ressa Na, Newman M> ;Cutis. 2016 Nov 1
- 14 citationsNatural rubber latex allergy.Steven L. Kahn, Joshua O. Podjasek, Vassilios A. Dimitropoulos, Clarence W. Brown> ;Disease-a-Month. 2016 Jan 1
- 4 citationsExcisional Debulking and Electrosurgery of Otophyma and Rhinophyma.Steven L. Kahn, Joshua O. Podjasek, Vassilios A. Dimitropoulos, Clarence W. Brown> ;Dermatologic Surgery. 2016 Jan 1
- Join now to see all
Professional Memberships
- Fellow
Hospital Affiliations
Corewell Health Lakeland HospitalSaint Joseph, Michigan
Evanston HospitalEvanston, Illinois
AMITA Health Resurrection Medical CenterChicago, Illinois
Skokie HospitalSkokie, Illinois
Highland Park HospitalHighland Park, Illinois
Glenbrook HospitalGlenview, Illinois
Battle Creek Veterans Affairs Medical CenterBattle Creek, Michigan
Captain James A. Lovell Federal Health Care CenterNorth Chicago, Illinois
AMITA Health Adventist Medical Center - HinsdaleHinsdale, Illinois
UChicago Medicine AdventHealth La GrangeLa Grange, Illinois- Ascension Saint FrancisEvanston, Illinois
University of Illinois HospitalChicago, Illinois
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
